poisar

Stocks · News reference

Guggenheim Maintains Buy on ANI Pharmaceuticals, Raises Price Target to $121

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ANIP
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Global Health Forum

    Global Health Congress 2026 Draws 625+ Leaders From 25 Countries to New York, Names Venture Forum Winners and Announces National and International Expansion

    The second annual Global Health Congress convened 625+ healthcare leaders from 25+ countries at the Yale Club of New York City (October 9-11, 2026). The Healthcare Shark Tank competition received 350+ startup applications from 35+ countries, with four winners announced: Stabilis Medical, Florence, Wink, and Braiv. Global Health Forum announced expansion plans for regional chapters across the United States and internationally in India, the United Kingdom, and the Middle East.

    BCSMSFTRXTANIP
  2. SEC EDGAR

    8-K filing — ANI PHARMACEUTICALS INC (ANIP)

    Filed: 2026-11-05 AccNo: 0001104659-26-123446 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    ANIP